17 NOVEL MEDIATORS OF CHONDROCYTE GENE EXPRESSION IN DEVELOPMENT AND OSTEOARTHRITIS  by Goldring, Mary B.
S8 Abstracts from Invited Speakers
to study cartilage matrix are currently (i) dGEMRIC (delayed
gadolinium enhanced magnetic resonance imaging of cartilage),
(ii) T2 relaxation time measurements and (iii) T1rho mapping
techniques. These techniques have shown merit in determining
the amount of macromolecules, such as glycosaminoglycans,
within the cartilage and quantifying its water content.
In summary MRI’s role in cartilage imaging is evolving with new
diagnostic requirements; while assessment of cartilage morphol-
ogy is still standard, innovative techniques to quantify matrix
changes at early stages will be increasingly important in the
future to tailor therapies and better understand disease progres-
sion on a molecular level.
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The human adult articular chondrocyte is a unique cell type
that has reached a terminally differentiated state within the car-
tilage matrix as an end-point of development. In cartilage of
patients with osteoarthritis (OA), the chondrocytes may undergo
phenotypic modulation in response to alterations in the environ-
ment due to the mechanical loading and inflammation. Isolated
chondrocytes in primary culture have provided useful models
to study cellular responses to alterations in the environment
such as those occurring in different forms of arthritis [1]. Immor-
talized chondrocytes of human origin have been developed to
serve as reproducible models for studying transcriptional regu-
lation of chondrocyte function by inflammatory mediators such
as interleukin-1β (IL-1β) [2]. We reported previously that activa-
tion of EGR-1 by IL-1β results in early, transient suppression of
proximal COL2A1 promoter activity by displacement of Sp1 from
GC boxes [3]. The epithelium-specific ETS (ESE)-1 is expressed
predominantly in epithelial cells but can also be induced in other
cell types including chondrocytes in response to inflammatory
mediators such as IL-1β and upregulates IL-1-induced genes,
including COX-2 [4,5]. ESE-1 is a potent transcriptional suppres-
sor of COL2A1 promoter activity in chondrocytes, accounting
for the sustained, NF-κB-dependent inhibition by IL-1β, and acts
by interfering with the activator functions of CBP/300 and Sox9
[6]. Our finding that ESE-1 protein is localized intracellularly in
chondrocytes in cartilage from patients with osteoarthritis but
not from individuals with normal joints and that IL-1β induces
ESE-1 expression in adult human articular chondrocytes further
suggest a fundamental role for ESE-1 in cartilage degeneration
and suppression of repair.
Recently, we have identified novel pathways that regulate chon-
drocyte terminal differentiation in the growth plate during endo-
chondral ossification and also modulate chondrocyte phenotype
in osteoarthritis. A microarray study of BMP-2-induced genes
resulted in the discovery of a novel role for growth arrest and
DNA damage inducible (GADD) 45β in chondrocyte survival and
up-regulation of MMP-13 and Col10a1 gene expression during
chondrogenesis [7,8]. The GADD45β gene product is implicated
in the stress response, cell cycle arrest and apoptosis. GADD45α
and γ, which are important mediators of tumor cell apoptosis,
are not upregulated by BMP-2. In recent studies, we have begun
to investigate the relative contributions of ESE-1 and GADD45β
to OA initiation and progression, since both factors up-regulate
MMP-13 gene expression and are expressed in early OA car-
tilage and at 3 to 6 months in the cho/+ mouse model, which
develops OA-like pathology due to mutations that disrupt the
collagen network [9]. We have also asked whether similar mech-
anisms regulate chondrocyte hypertrophy both during remod-
eling of the calcified cartilage matrix of the hypertrophic zone
of the growth plate and during tidemark advancement in OA.
Both processes share the features of chondrocyte hypertrophy,
apoptosis and MMP-13-mediated remodeling. The distribution
of immunostaining for GADD45β in early OA cartilage at sites
peripheral to the lesion in chondrocyte clusters and in deep zone
chondrocytes, along with our finding that it suppresses apop-
tosis, suggests that GADD45β may serve as a survival factor
in activated chondrocytes, while promoting hypertrophy during
tidemark advancement. An understanding of the relative contri-
butions of the GADD45β and ESE-1 pathways to physiological
cartilage homeostasis will provide understanding of the molecular
mechanisms responsible for dysregulated cartilage remodeling
in joint disease.
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GENETIC INFLUENCES ON OSTEOARTHRITIS: AN
UPDATE
Tim D. Spector
A number of studies in the last few years have shown unequiv-
ocal evidence that at least 50% of the variance of OA in the
hands, knees and hips is accounted for by genetic factors. These
include classical twin studies of unselected populations as well
as population based family studies and affected sib pair studies.
A genetic effect on spinal disk degeneration, and spinal osteo-
phytes, has also been demonstrated in twins using MRI data.
